Join clinical microbiology laboratory directors in discussing recent journal articles in clinical microbiology. Each month, a group of presenters will discuss 1-2 articles in depth. Journal clubs are held every second Tuesday of the month at 2 p.m. ET.

This activity is free to ASM members.

Next Session: Phage Therapy and Implications for the Clinical Microbiology Laboratory—August 13, 2024

Learning Objectives

• Discuss the role of phage therapy in the treatment of antimicrobial-resistant infections.
• Identify clinical situations in which phage therapy might be considered.
• Describe susceptibility testing methods for clinical phage.
• Discuss the implications of increasing the utilization of phage therapy for the clinical microbiology laboratory.

Articles

• Le T, Nang SC, et al. 2023. Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections. Antimicrobial Agents and Chemotherapy 67:e00037-23.
• Parmar K, Komarow L, et al. 2023. Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing. Journal of Clinical Microbiology 61:e00614-23.

Presenters

• Filipe Cerqueira, Ph.D., Associate Director of Clinical Microbiology, University of Alabama at Birmingham Hospitals, assistant professor, University of Alabama at Birmingham.
• Alexis Jaramillo Cartagena, Ph.D., CPEP medical and public health microbiology fellow, Memorial Sloan Kettering Cancer Center.

Moderator

• Belkys C. Sánchez, Ph.D., M.Sc., Associate Director of the Microbiology Diagnostic Laboratory, Houston Methodist Hospital.

Discussion Panel

• Saima Aslam, M.B.B.S., ABIM, Medical Director, Solid Organ Transplant Infectious Diseases, Clinical Lead, Center for Innovative Phage Applications and Therapeutics, associate professor, University of California San Diego.
• Gregory German, M.D., Ph.D., FRCPC, DTM&H (UK), medical microbiologist, Unity Health Toronto, Associate Professor, University of Toronto.
• Krupa Parmar, Ph.D., phage therapy research technologist, Mayo Clinic.
• Patricia Simner, Ph.D., D(ABMM), Director of the Medical Bacteriology and Infectious Disease Sequencing Laboratories, Johns Hopkins Hospital, Professor, Johns Hopkins University School of Medicine.

Continuing Education (CE) Credit

Each 2023 presentation is approved for 1.0 P.A.C.E.^® credit. ASM is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.^® Program. All presentations are recognized by the California Department of Health and Florida Department of Health and qualify for California and Florida CE credit toward license renewal. CE credits are available for a $10 fee and can only be claimed by the learner. Learners can add this fee to their cart by visiting the individual session pages. CEs cannot be purchased from the series page.

Please note that CEs will no longer be offered starting with the 2024 sessions. CEs for the 2023 sessions are available until the session expires.

Want To Present or Join the Discussion?

ASM is looking for experts in the clinical laboratory to present and discuss relevant journal articles for its Clinical Microbiology Virtual Journal Club.

Commitment

• 1 session commitment (1 hour).
• 2-5 hours per session.

Responsibilities and Expectations

• Presenter:
  • Coordinate with the session coordinator to find a recent journal article on clinical microbiology (preferably open access or ASM).
  • Create a 15-minute (max) presentation on the confirmed article.
  • Present during the live session held on the second Tuesday of the month.
• Discussion Panelist:
  • Read the 2 articles confirmed for the session you are assigned.
  • Participate in the live discussion on the second Tuesday of the month.

Eligibility

• ASM membership required.
• Preferred: A subject-matter expert in a clinical or public health lab, a laboratory director or a laboratory fellow.

Archives

Missed a past virtual journal club? Catch up by watching recordings on ASM Events Online.